Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?
Journal Title: Otolaryngologia Polska - Year 2015, Vol 69, Issue 1
Abstract
It’s been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun.This publication presents current concepts on application of intranasal glucocorticosteroids in treatment of upper airway diseases and in particular of allergic rhinitis and rhinosinusitis.The non-questionable advantage of intranasal glucocorticosteroids is their strong anti-inflammatory local action with little impact on general health responsible for few and benign side effects. Main way of action of glucocorticosteroids is connected with binding to the intracellular glucocorticosteroid receptor and its impact on nuclear cytoplasmic transcriptional factors. Glucocorticosteroids suppress gene expression of factors responsible for generating and supporting inflammatory processes, pro-inflammatory cytokines and chemokines production, adhesive molecules expression. It appears that glucocorticosteroids has also other mechanisms of action, non-involving intracellular receptors, leading to inhibiting of early and late phase of allergic reaction.At the moment there are following glucocorticosteroids registered in Poland: beclomethasone, budesonide, fluticasone propionate, fluticasone fuorate, mometasonefuorate. Special attention earns fuorates as their lateral fuorate ester chain makes this molecules highly lipophilic, easily absorbed by nasal mucous membranes epithelium and cell membranes phospholipids. This minimizes their general action and maximizes local action. According to current state of knowledge topical glucocorticosteroids are used in the following upper airway diseases with different inflammatory mechanism: allergic rhinitis, non-allergic rhinitis, particularly NARES, acute rhinosinusitis, chronic rhinosinusitis with and without nasal polyps, adenoid hypertrophy and rhinitis in bronchial asthma.
Authors and Affiliations
Anna Nowicka, Bolesław Samoliński
Keywords
Related Articles
- EP ID EP52575
- DOI -
- Views 127
- Downloads 0
Polymorphism of metalloproteinases MMP-1 and MMP-2 in risk of Iaryngeal cancer
SUMMARY Introduction: The laryngeal cancer is the most common malignancy of the head and neck squamous celt carcinoma. Recent studies have revealed the role of genetic variations in the risk for laryngeal cancer. Polymor...
A case of maxillary sinus carcinoma of a 24-years-old man, holistic aspects of care
SUMMARY The aim of this study is to report a carcinoma affecting the maxillary sinus of a 24-years old man. Malignant tumors of the nasal cavity and paranasal sinuses are rare and a very heterogeneous group of tumors. Th...
Head and neck tuberculosis — stili current problem in ENT practice
SUMMARY Introduction: It is estimated that between XVI and XIX century one fourth of European population died of tuberculosis. Nowadays tuberculosis is stili one of the most important infectious diseases. In 2009 estimat...
Przypadek olbrzymiego gruczolaka wielopostaciowego przyusznicy
Introduction. A case of pleomorphic adenoma of the parotid gland was reported. Pleomorphic adenoma is the most common benign tumor of the major salivary glands. A review of the literature confi rms that this kind of tumo...
Porównanie jakości głosu osób z refluksowymi zmianami w krtani i gardle dolnym przed i po leczeniu
Cel: Ocena jakości głosu osób z refluksowymi zmianami w krtani i gardle dolnym przed i po leczeniu.Materiał i metodyka: Materiał stanowiło 249 osób, u których w badaniu VLS rozpoznano cechy refluksowego zapalenia krtani...